5PSQ-032 Administration protocol for penicillin G in a patient with a severe reaction to betalactams and abdominal actinomycosis

• Published in: European journal of hospital pharmacy. Science and practice 2019-03, Vol.26 (Suppl 1), p.A216-A216
• Main Authors: Izquierdo, E, Lazaro-Cebas, A, Carreño-Ocaña, A, Blanca-Lopez, N, Ruano-Perez, FJ, Such-Diaz, A, Tejedor-Prado, P, Alvaro-Alonso, EA, Santiago-Perez, A, Canto-Diez, MG, Escobar-Rodriguez, I
• Format: Article
• Language: English
• Subjects: Abdomen; Antibiotics; Penicillin
• ISSN: 2047-9956; 2047-9964
• DOI: 10.1136/ejhpharm-2019-eahpconf.465

BackgroundPenicillin G 20 MIU/day for 4–6 weeks followed by oral amoxicillin for 6–12 months is the first option of treatment for abdominal actinomycosis where other therapies have less effectiveness.PurposeTo describe a desensitisation protocol for Penicillin G in a patient with abdominal actynomicosis that had experienced a severe anaphylactic reaction (tachycardia, redness, bronchospasm and refractory hypotension) to ceftriaxone that required a perfusion of noradrenalina, in addition to adrenaline, corticosteroids and salbutamol for recovering.Material and methodsPenicillin G vials were reconstituted with water for injection as indicated on its label and they were diluted with 0.9% sodium chloride to make four mother solutions (0.1 mg/ml, 1 mg/ml, 10 mg/ml and 100 mg/ml of β-lactamic). Doses were prepared in syringes. Initial dose was 16 IU, with subsequent syringes elaborated doubling the dose until a cumulative dose of 5 MIU. A total of 19 syringes were prepared in a horizontal laminar flow cabinet in the pharmacy service: dilution 0.1 mg/ml (160 IU/ml): 16 IU/0.1 ml, 32 IU/0.2 ml, 64 IU/0.4 ml and 128 IU/0.8 ml. Dilution 1 mg/ml (1,600 IU/ml): 240 IU/0.15 ml, 480 IU/0.3 ml, 960 IU/0.6 ml and 1,600 IU/1 ml. Dilution 10 mg/ml (16,000 IU/ml): 3,200 IU/0.2 ml, 6,400 IU/0.4 ml and 12,800 IU/0.8 ml. Dilution 100 mg/ml (160,000 IU/ml): 24,000 IU/0.15 ml, 48,000 IU/0.3 ml, 96,000 IU/0.6 ml, 16,000 IU/1 ml, 320,000 IU/2 ml, 640,000 IU/4 ml, 1,280,000 IU/8 ml and 2,400,000 IU/15 ml.ResultsDue to the high risk of the patient, despite negative allergological tests, a desensitisation protocol was administrated by allergists in the intensive care unit with monitoring and cardiopulmonary resuscitation equipment. The time interval between each syringe was 10 min in direct bolus, the last three doses were administered during 10–15 min due to the higher doses and infusion pain. The schedule was achieved without any reaction. After this, a whole dose of 5 MUI/6 hours was administered during 2 months without any adverse reaction.ConclusionThis desensitisation protocol can be useful for penicillin-allergic patients without alternative treatment options.References and/or acknowledgementsDávila González IJ, Sociedad Española de Alergología e Inmunología Clínica. Tratado de alergología. 2nd Ed. Vol. 2. Majadahonda: Ergón; 2016.No conflict of interest.